BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33302860)

  • 1. Vitiligo: An Updated Narrative Review.
    Leung AKC; Lam JM; Leong KF; Hon KL
    Curr Pediatr Rev; 2021; 17(2):76-91. PubMed ID: 33302860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
    Ju HJ; Han JH; Kim MS; Lee SH; Shin JW; Choi M; Jeong KH; Han TY; Choi CW; Lee HJ; Oh SH; Lee SH; Kim DH; Shin J; Lee JH; Kim SS; Kang HY; Chang SE; Kim JS; Lee DY; Choi GS; Suh DH; Chan Kim Y; Park CJ; Kim KH; Lee AY; Chan Park K; Lee MH; Bae JM;
    J Am Acad Dermatol; 2021 Jun; 84(6):1619-1627. PubMed ID: 33508387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of Janus kinase inhibitors and narrowband ultraviolet B combination therapy in non-segmental vitiligo.
    Yousefian F; Yadlapati S; Browning JC
    J Cosmet Dermatol; 2023 Mar; 22(3):1105-1107. PubMed ID: 36440703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home phototherapy in vitiligo.
    Mohammad TF; Silpa-Archa N; Griffith JL; Lim HW; Hamzavi IH
    Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):241-252. PubMed ID: 28620923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline for the diagnosis and management of vitiligo.
    Gawkrodger DJ; Ormerod AD; Shaw L; Mauri-Sole I; Whitton ME; Watts MJ; Anstey AV; Ingham J; Young K; ; ; ;
    Br J Dermatol; 2008 Nov; 159(5):1051-76. PubMed ID: 19036036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood Vitiligo.
    Nicolaidou E; Mastraftsi S; Tzanetakou V; Rigopoulos D
    Am J Clin Dermatol; 2019 Aug; 20(4):515-526. PubMed ID: 30911977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review.
    Ju HJ; Bae JM
    Dermatology; 2024; 240(3):474-486. PubMed ID: 38417409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic management of vitiligo.
    Bleuel R; Eberlein B
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1309-1313. PubMed ID: 30335222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs).
    Bae JM; Hong BY; Lee JH; Lee JH; Kim GM
    J Am Acad Dermatol; 2016 May; 74(5):907-15. PubMed ID: 26785803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligoid variant of lichen sclerosus in young girls with darker skin types.
    Dennin MH; Stein SL; Rosenblatt AE
    Pediatr Dermatol; 2018 Mar; 35(2):198-201. PubMed ID: 29314207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phototherapy for Vitiligo.
    Zubair R; Hamzavi IH
    Dermatol Clin; 2020 Jan; 38(1):55-62. PubMed ID: 31753192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta-analysis.
    Dang YP; Li Q; Shi F; Yuan XY; Liu W
    Dermatol Ther; 2016; 29(2):126-33. PubMed ID: 26460804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study on the characteristics and treatment of late-onset vitiligo.
    Kong YL; Ching VHL; Chuah SY; Thng TG
    Indian J Dermatol Venereol Leprol; 2017; 83(5):625. PubMed ID: 28656913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic and targeted therapeutics in vitiligo.
    Karagaiah P; Schwartz RA; Lotti T; Wollina U; Grabbe S; Goldust M
    J Cosmet Dermatol; 2023 Jan; 22(1):64-73. PubMed ID: 35029034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of JAK and IL-23 inhibitors to treat vitiligo.
    Lee H; Cowan TL; Daniel BS; Murrell DF
    Australas J Dermatol; 2023 May; 64(2):204-212. PubMed ID: 36810815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of combination use of phenytoin cream 1% and fractional CO
    Abasifar H; Ghalamkarpour F; Diab R; Abdollahimajd F
    Dermatol Ther; 2022 Aug; 35(8):e15635. PubMed ID: 35699662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo treatment in childhood: a state of the art review.
    Tamesis ME; Morelli JG
    Pediatr Dermatol; 2010; 27(5):437-45. PubMed ID: 20553403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo: an update on systemic treatments.
    Searle T; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Management of Pediatric Vitiligo.
    Van Driessche F; Silverberg N
    Paediatr Drugs; 2015 Aug; 17(4):303-13. PubMed ID: 26022363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.